Newsroom

Cutting-Edge Research. Translational Science.

Presentations

WATCH HERE

Scientific Publications

CRISPR gene editing: Can we make cancer cells easier to kill?
Author: Eric B. Kmiec
Journal: Research Outreach (Page 62) 2024
CRISPR-Directed Gene Editing as a Method to Reduce Chemoresistance in Lung Cancer Cells
Authors: Rivera-Torres N, Bialk P, Kmiec EB
Book: Cancer Systems and Integrative Biology, 2023
Exon skipping induced by CRISPR-directed gene editing regulates the response to chemotherapy in non-small cell lung carcinoma cells
Authors: Banas K, Modarai S, Rivera-Torres N, Yoo B-C, Bialk P, Barrett C, Batish M, Kmiec EB
Journal: Gene Therapy, 2022
Potential Inequities in New Medical Technologies
Authors: Kmiec EB, Marron J
Journal: Scientific American, 2020
Kinetics of Nuclear Uptake and Site-Specific DNA Cleavage during CRISPR-Directed Gene Editing in Solid Tumor Cells
Authors: Banas K, Rivera-Torres N, Bialk P, Yoo BC, Kmiec EB
Journal: Molecular Cancer Research, 2020
Functional Gene Knockout of NRF2 Increases Chemosensitivity of Human Lung Cancer A549 Cells in Vitro and in Xenograft Mouse Model
Authors: Bialk P, Wang Y, Banas K, Kmiec EB
Journal: Molecular Therapy Oncolytics, 2018

Latest News

RealLIST Connectors 2024: Meet 20 of the most impactful leaders in Delaware’s innovation scene
Publication: Technical.ly
CorriXR: How This Company Is Using CRISPR/Cas Gene Editing To Develop New Medicines
Publication: Pulse 2.0
RealLIST Startups 2024: Delaware’s most promising early-stage companies
Publication: Technical.ly
CorriXR sees investment from Oklahoma investment firm
Publication: Delaware Business Times
Therapeutic Gene Editing: A Lot Done, a Lot More to Do. Interview with Eric Kmiec, Ph.D.
Publication: CRISPR Medicine News
Cortado Ventures Invests in CorriXR
Source: Cortado Ventures
ChristianaCare spinout CorriXR is off to the races
Publication: Technical.ly
CorriXR Therapeutics names Moorad as new CEO
Publication: Delaware Business Times
CorriXR Therapeutics Announces Deborah Moorad as Its New Chief Executive Officer
Publication: Business Wire
Eric Kmiec, Ph.D., Named Editor-in-Chief of Gene and Genome Editing
Publication: ChristianaCare News
Education & Healthcare: Collaborating on the Path to Innovation
Publication: Innovation Delaware - Delaware Business Times Special Edition
Delaware leads in gene-editing CRISPR tech
Publication: Delaware Business Times
Delaware BioScience Association Announces Most Promising New Company Competition Winner
Publication: Delaware BioScience Association
CorriXR Therapeutics wins inaugural Delaware DNA pitch contest
Publication: Delaware Business Times
CRISPR : Can it Cure Disease or is it Playing God?
Podcast: The Smartest Doctor in the Room
This CRISPR Researcher Says Gene Editing Isn't Playing God
Publication: Futurism
Profiles in Innovation: Dr. Eric Kmiec
Publication: Choose Delaware
ChristianaCare explores using CRISPR in cancer treatment, starts talks with FDA
Publication: The Cancer Letter
ChristianaCare Spins Out First Commercial Gene Editing Biotechnology Start-Up Company, CorriXR Therapeutics
Publication: ChristianaCare News
CRISPR Makes Resistant Lung Cancer Cells Vulnerable to Chemotherapy
Publication: CRISPR Medicine News
Gene Editing: Making the Impossible Possible with Drs. Eric Kmiec & Natalia Rivera-Torres
Podcast: Lungcast with the American Lung Association
CRISPR-Induced Gene Products Control Response to Therapy in Lung Cancer Cells
Publication: Genetic Engineering News
Scientists Put CRISPR on Safer Path to Patient Treatments With New Way to Evaluate Impacts of Gene Edits
Publication: ChristianaCare News
Unlike at Other Labs, Women Scientists Thrive at ChristianaCare’s Gene Editing Institute
Publication: ChristianaCare News

Contact Us

Reach out to discuss partnerships to advance our technology.

Contact